Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir post-exposure prophylaxis for Lassa virus exposure
jRCTs031240114Recruiting
- Sponsor
- Health and Labour Sciences Research Grants
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of favipiravir in Lassa fever, sponsored by Health and Labour Sciences Research Grants. Primary endpoint: Development of Lassa fever during the study period. Started Jun 2024; status: recruiting.
02
Drugs
favipiravir
03
Conditions
Lassa fever
Beyond the preview
Go deeper on jRCTs031240114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031240114.